STACCHIOTTI, SILVIA
STACCHIOTTI, SILVIA
Universita' degli Studi di MILANO
Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib
2022 S. Hidalgo-Ríos, J. Carrillo-García, D.S. Moura, S. Stacchiotti, A. López-Pousa, A. Redondo, A. Italiano, A. Gutiérrez, G. Grignani, N. Hindi, J. López-Guerrero, X.G.D. Muro, J.M. Trufero, E. Palmerini, A.S. García, D. Bernabeu, A. Le Cesne, P.G. Casali, J. Blay, J. Cruz Jurado, J. Martin-Broto
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study
2022 A.M. Frezza, S. Stacchiotti, F. Chibon, J. Coindre, A. Italiano, C. Romagnosa, S. Bagué, A.P. Dei Tos, L. Braglia, E. Palmerini, V. Quagliuolo, J.M. Broto, A. Lopez Pousa, G. Grignani, A. Brunello, J. Blay, R.D. Beveridge, I. Lugowska, T. Lesluyes, R. Maestro, F.D. Merlo, P.G. Casali, A. Gronchi
Rechallenge of denosumab in advanced giant cell tumor of the bone after atypical femur fracture: A case report and review of literature
2022 V. Nasca, A.M. Frezza, C. Morosi, C. Buonomenna, A. Parafioriti, G. Zappalà, F. Bini, P.G. Casali, M. Loppini, S. Stacchiotti
Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literature
2021 A.M. Frezza, V. Ravi, S. Lo Vullo, B. Vincenzi, F. Tolomeo, T.W.-. Chen, P. Teterycz, G.G. Baldi, A. Italiano, N. Penel, A. Brunello, F. Duffaud, N. Hindi, S. Iwata, A. Smrke, A. Fedenko, H. Gelderblom, W. Van Der Graaf, A. Vozy, E. Connolly, M. Grassi, R.S. Benjamin, J.-. Broto, G. Grignani, R.L. Jones, A. Kawai, A. Tysarowski, L. Mariani, P.G. Casali, S. Stacchiotti
Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect?
2021 M. Danieli, F. Barretta, M. Fiore, S. Radaelli, C. Sangalli, M. Barisella, S. Stacchiotti, E. Palassini, R. Miceli, D. Callegaro, P.G. Casali, A. Gronchi
Clinical prognostic factors in advanced epithelioid haemangioendothelioma : a retrospective case series analysis within the Italian Rare Cancers Network
2021 A.M. Frezza, A. Napolitano, R. Miceli, G. Badalamenti, A. Brunello, C. Buonomenna, P.G. Casali, A. Caraceni, G. Grignani, A. Gronchi, G. Infante, C. Morosi, L. Saita, N. Simeone, N. Zaffaroni, B. Vincenzi, S. Stacchiotti
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up ☆
2021 S.J. Strauss, A.M. Frezza, N. Abecassis, J. Bajpai, S. Bauer, R. Biagini, S. Bielack, J.Y. Blay, S. Bolle, S. Bonvalot, I. Boukovinas, J.V.M.G. Bovee, K. Boye, B. Brennan, T. Brodowicz, A. Buonadonna, E. de Alava, A.P. Dei Tos, X. Garcia del Muro, A. Dufresne, M. Eriksson, F. Fagioli, A. Fedenko, V. Ferraresi, A. Ferrari, N. Gaspar, S. Gasperoni, H. Gelderblom, F. Gouin, G. Grignani, A. Gronchi, R. Haas, A.B. Hassan, S. Hecker-Nolting, N. Hindi, P. Hohenberger, H. Joensuu, R.L. Jones, C. Jungels, P. Jutte, L. Kager, B. Kasper, A. Kawai, K. Kopeckova, D.A. Krakorova, A. Le Cesne, F. Le Grange, E. Legius, A. Leithner, A. Lopez Pousa, J. Martin-Broto, O. Merimsky, C. Messiou, A.B. Miah, O. Mir, M. Montemurro, B. Morland, C. Morosi, E. Palmerini, M.A. Pantaleo, R. Piana, S. Piperno-Neumann, P. Reichardt, P. Rutkowski, A.A. Safwat, C. Sangalli, M. Sbaraglia, S. Scheipl, P. Schoffski, S. Sleijfer, D. Strauss, K. Sundby Hall, A. Trama, M. Unk, M.A.J. van de Sande, W.T.A. van der Graaf, W.J. van Houdt, T. Frebourg, R. Ladenstein, P.G. Casali, S. Stacchiotti
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
2021 S. Stacchiotti, A.B. Miah, A.M. Frezza, C. Messiou, C. Morosi, A. Caraceni, C.R. Antonescu, J. Bajpai, E. Baldini, S. Bauer, R. Biagini, S. Bielack, J.Y. Blay, S. Bonvalot, I. Boukovinas, J.V.M.G. Bovee, K. Boye, T. Brodowicz, D. Callegaro, E. De Alava, M. Deoras-Sutliff, A. Dufresne, M. Eriksson, C. Errani, A. Fedenko, V. Ferraresi, A. Ferrari, C.D.M. Fletcher, X. Garcia del Muro, H. Gelderblom, R.A. Gladdy, F. Gouin, G. Grignani, J. Gutkovich, R. Haas, N. Hindi, P. Hohenberger, P. Huang, H. Joensuu, R.L. Jones, C. Jungels, B. Kasper, A. Kawai, A. Le Cesne, F. Le Grange, A. Leithner, H. Leonard, A. Lopez Pousa, J. Martin Broto, O. Merimsky, P. Merriam, R. Miceli, O. Mir, M. Molinari, M. Montemurro, G. Oldani, E. Palmerini, M.A. Pantaleo, S. Patel, S. Piperno-Neumann, C.P. Raut, V. Ravi, A.R.A. Razak, P. Reichardt, B.P. Rubin, P. Rutkowski, A.A. Safwat, C. Sangalli, G. Sapisochin, M. Sbaraglia, S. Scheipl, P. Schoffski, D. Strauss, S.J. Strauss, K. Sundby Hall, W.D. Tap, A. Trama, A. Tweddle, W.T.A. van der Graaf, M.A.J. Van De Sande, W. Van Houdt, G. van Oortmerssen, A.J. Wagner, M. Wartenberg, J. Wood, N. Zaffaroni, C. Zimmermann, P.G. Casali, A.P. Dei Tos, A. Gronchi
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
2021 V. Zuco, S. Pasquali, M. Tortoreto, S. Brich, S. Percio, G.P. Dagrada, C. Colombo, R. Sanfilippo, C. Lauricella, M. Gounder, R. El Bezawy, M. Barisella, A.P. Dei Tos, P.G. Casali, A. Gronchi, S. Stacchiotti, N. Zaffaroni
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas : Final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups
2020 A. Gronchi, E. Palmerini, V. Quagliuolo, J.M. Broto, A. Lopez Pousa, G. Grignani, A. Brunello, J.-. Blay, O. Tendero, R. Diaz Beveridge, V. Ferraresi, I. Lugowska, D. Franco Merlo, V. Fontana, E. Marchesi, L. Braglia, D. Maria Donati, E. Palassini, G. Bianchi, A. Marrari, C. Morosi, S. Stacchiotti, S. Bague, J.M. Coindre, A.P. Dei Tos, P. Picci, P. Bruzzi, P.G. Casali
Pazopanib for treatment of typical solitary fibrous tumours : a multicentre, single-arm, phase 2 trial
2020 J. Martin-Broto, J. Cruz, N. Penel, A. Le Cesne, N. Hindi, P. Luna, D.S. Moura, D. Bernabeu, E. de Alava, J.A. Lopez-Guerrero, J. Dopazo, M. Pena-Chilet, A. Gutierrez, P. Collini, M. Karanian, A. Redondo, A. Lopez-Pousa, G. Grignani, J. Diaz-Martin, D. Marcilla, A. Fernandez-Serra, C. Gonzalez-Aguilera, P.G. Casali, J.-. Blay, S. Stacchiotti
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors : A Multicenter, European Retrospective Case Series Analysis
2020 G.G. Baldi, M. Brahmi, S. Lo Vullo, E. Cojocaru, O. Mir, M. Casanova, B. Vincenzi, T.M. De Pas, G. Grignani, M.A. Pantaleo, J.Y. Blay, R.L. Jones, A. Le Cesne, A.M. Frezza, A. Gronchi, P. Collini, A.P. Dei Tos, C. Morosi, L. Mariani, P.G. Casali, S. Stacchiotti
Rechallenge of denosumab in jaw osteonecrosis of patients with unresectable giant cell tumour of bone: A case series analysis and literature review
2020 A. Raimondi, N. Simeone, M. Guzzo, M. Maniezzo, P. Collini, C. Morosi, F.G. Greco, A.M. Frezza, P.G. Casali, S. Stacchiotti
Community-based rehabilitation program for cerebral PALSY (CP) children in North Uganda
2019 L. Alberghina, E. Ochola, C. Turibamwe, V. Omona, S. Stacchiotti, C. Malloggi, V. Rota, L. Tesio
Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour : a multicentre, single-arm, phase 2 trial
2019 J. Martin-Broto, S. Stacchiotti, A. Lopez-Pousa, A. Redondo, D. Bernabeu, E. de Alava, P.G. Casali, A. Italiano, A. Gutierrez, D.S. Moura, M. Peña-Chilet, J. Diaz-Martin, M. Biscuola, M. Taron, P. Collini, D. Ranchere-Vince, X. Garcia del Muro, G. Grignani, S. Dumont, J. Martinez-Trufero, E. Palmerini, N. Hindi, A. Sebio, J. Dopazo, A.P. Dei Tos, A. Lecesne, J. Blay, J. Cruz
Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients—A propensity score analysis
2019 E. Nizri, M. Fiore, C. Colombo, S. Radaelli, D. Callegaro, R. Sanfilippo, C. Sangalli, P. Collini, C. Morosi, S. Stacchiotti, P.G. Casali, A. Gronchi
Role of chemotherapy, VEGFR inhibitors and mTOR Inhibitors in advanced Perivascular Epithelioid Cell Tumours (PEComas)
2019 R. Sanfilippo, R.L. Jones, J. Blay, A. Le Cesne, S. Provenzano, G. Antoniou, O. Mir, G. Fucà, E. Fumagalli, R. Bertulli, S. Stacchiotti, M. Brahmi, F. Grosso, A. Dufresne, N. Hindi, M. Sbaraglia, A. Gronchi, P. Collini, A.P. Dei Tos, P.G. Casali
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial
2019 S. Stacchiotti, S. Ferrari, A. Redondo, N. Hindi-Muniz, E. Palmerini, M.A. Vaz Salgado, A.M. Frezza, P.G. Casali, A. Gutierrez, A. Lopez-Pousa, G. Grignani, A. Italiano, A. Lecesne, S. Dumont, J.Y. Blay, N. Penel, D. Bernabeu, E. de Alava, M. Karanian, C. Morosi, S. Brich, G.P. Dagrada, V. Vallacchi, C. Castelli, M. Brenca, D. Racanelli, R. Maestro, P. Collini, J. Cruz, J. Martin-Broto
Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study
2019 S. Stacchiotti, N. Simeone, S. Lo Vullo, C. Morosi, F.G. Greco, A. Gronchi, M. Barisella, P. Collini, N. Zaffaroni, G.P. Dagrada, A.M. Frezza, L. Mariani, P.G. Casali
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma : revisiting the results of the EORTC-STBSG 62931 randomised trial
2019 S. Pasquali, S. Pizzamiglio, N. Touati, S. Litiere, S. Marreaud, B. Kasper, H. Gelderblom, S. Stacchiotti, I. Judson, A.P. Dei Tos, P. Verderio, P.G. Casali, P.J. Woll, A. Gronchi